 Global Cord Blood Corporation NYSE: CO GCBC or the Company, Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019 novel coronavirus COVID-19 on the Companys expected fiscal 2021 operations. 